The lipopeptide antibiotic paenibacterin binds to the bacterial outer membrane and exerts bactericidal activity through cytoplasmic membrane damage

Applied and Environmental Microbiology

Volumn 80, Issue 9, 2014, Pages 2700-2704

  Huang, En ^a   Yousef, Ahmed E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACTERIA; BACTERICIDES; CELL MEMBRANES; ESCHERICHIA COLI;

ANTI-MICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; BACTERICIDAL MECHANISMS; CYTOPLASMIC MEMBRANE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIUM; MEMBRANE POTENTIALS; STAPHYLOCOCCUS AUREUS;

MEMBRANES;

ANTIINFECTIVE AGENT; LIPOPEPTIDE; OUTER MEMBRANE PROTEIN; PAENIBACTERIN;

CELL MEMBRANE; DRUG EFFECTS; ESCHERICHIA COLI; METABOLISM; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CELL MEMBRANE; ESCHERICHIA COLI; LIPOPEPTIDES; STAPHYLOCOCCUS AUREUS;

EID: 84898670745     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03775-13     Document Type: Article

References (14)

1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1-12. http://dx.doi.org/10.1086/595011.
2. Guo Y, Huang E, Yuan C, Zhang L, Yousef AE. 2012. Isolation of a Paenibacillus sp. strain and structural elucidation of its broad-spectrum lipopeptide antibiotic. Appl. Environ. Microbiol. 78:3156-3165. http://dx.doi.org/10.1128/AEM.07782-11.
3. Huang E, Guo Y, Yousef AE. 2012. Draft genome sequence of Paenibacillus sp. strain OSY-SE, a bacterium producing the novel broad-spectrum lipopeptide antibiotic paenibacterin. J. Bacteriol. 194:6306. http://dx.doi.org/10.1128/JB.01506-12.
4. Hancock REW, Sahl HG. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557. http://dx.doi.org/10.1038/nbt1267.
5. Velkov T, Thompson PE, Nation RL, Li J. 2010. Structure-activity relationships of polymyxin antibiotics. J. Med. Chem. 53:1898-1916. http://dx.doi.org/10.1021/jm900999h.
6. Zhang L, Dhillon P, Yan H, Farmer S, Hancock REW. 2000. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44: 3317-3321. http://dx.doi.org/10.1128/AAC.44.12.3317-3321.2000.
7. Silverman JA, Perlmutter NG, Shapiro HM. 2003. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47:2538-2544. http://dx.doi.org/10.1128/AAC.47.8.2538-2544.2003.
8. Hancock REW. 1997. Peptide antibiotics. Lancet 349:418-422. http://dx.doi.org/10.1016/S0140-6736(97)80051-7.
9. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. 2002. Molecular biology of the cell. Garland Science, New York, NY.
10. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
11. Hurdle JG, O'Neill AJ, Chopra I, Lee RE. 2011. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat. Rev. Microbiol. 9:62-75. http://dx.doi.org/10.1038/nrmicro2474.
12. Hashizume H, Sawa R, Harada S, Igarashi M, Adachi H, Nishimura Y, NomotoA. 2011. TripropeptinCblocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate. Antimicrob. AgentsChemother. 55:3821-3828. http://dx.doi.org/10.1128/AAC.00443-11.
13. Schneider T, Gries K, Josten M, Wiedemann I, Pelzer S, Labischinski H, Sahl HG. 2009. The lipopeptide antibiotic friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob. Agents Chemother. 53:1610-1618. http://dx.doi.org/10.1128/AAC.01040-08.
14. Moore RA, Bates NC, Hancock R. 1986. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob. Agents Chemother. 29: 496-500. http://dx.doi.org/10.1128/AAC.29.3.496.